西梅普雷维尔
病毒学
单纯疱疹病毒
丙型肝炎病毒
生物
病毒
NS3型
利巴韦林
作者
Zheng Li,Fujia Yao,Guang Xue,Yongfen Xu,Jianlou Niu,Mengmeng Cui,Hongbin Wang,Shuangyan Wu,Ailing Lu,Jin Zhong,Guangxun Meng
标识
DOI:10.1016/j.antiviral.2019.104607
摘要
Simeprevir was developed as a small molecular drug targeting the NS3/4A protease of hepatitis C virus (HCV). Unexpectedly, our current work discovered that Simeprevir effectively promoted the transcription of IFN-β and ISG15, inhibited the infection of host cells by multiple viruses including Zika virus (ZIKV), Enterovirus A71 (EV-A71), as well as herpes simplex virus type 1 (HSV-1). However, the inhibitory effects of Simeprevir on ZIKV, EV-A71 and HSV-1 were independent from IFN-β and ISG15. This study thus demonstrates that the application of Simeprevir can be extended to other viruses besides HCV.
科研通智能强力驱动
Strongly Powered by AbleSci AI